ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

April 19, 2002

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Leukemia & Lymphoma Society offers translational research grants.

October 24, 2003

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012